Healing & Recovery Protocol

Apelin-13Complete Dosing & Administration Guide

A natural heart hormone that helps your cardiovascular system work better and supports healthy blood flow throughout your body.

Dose Range

As prescribed-As prescribedmg

Frequency

Once daily

Route

Intravenous (IV)

Cycle Length

Ongoing/indefinite

Dosing

How much
do I take?

Timing

Best time to take

Apelin-13 is administered intravenously in a clinical setting. Timing is determined by your healthcare provider based on the treatment protocol and your medical needs.

With food?

IV administration of Apelin-13 is not dependent on meal timing. Your healthcare team will provide specific instructions regarding food and fluid intake around treatment sessions.

If stacking

Apelin-13 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

+You've tolerated the current dose for the recommended period without significant side effects
+Therapeutic goals haven't been met at the current dose level
+Your healthcare provider recommends dose escalation based on your response
+Lab work or clinical assessments support a higher dose

Decrease if

-Side effects are bothersome or impacting daily life despite management strategies
-You experience any signs of an adverse reaction
-Lab results indicate the need for dose reduction
-Your healthcare provider recommends a lower dose based on your response

Signs of right dose

✓Therapeutic goals being met with minimal side effects
✓Stable and consistent response to treatment
✓Lab values or clinical markers trending in the right direction
✓Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

5mg

Look here!

The weight is on the label

5mg

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

•Apelin-13 vial (lyophilized powder or solution)
•Bacteriostatic water or sterile sodium chloride for reconstitution
•Alcohol swabs for cleaning vial tops and injection sites
•Appropriately sized syringes with fine-gauge needles (27-30 gauge)
•Sharps disposal container

Example

Add the recommended volume of bacteriostatic water to the Apelin-13 vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Your dose of Apelin-13 is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

•Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
•Front of thighs—middle to upper portion of the outer leg
•Back of upper arm—outer area (may need assistance from another person)

Technique

1.Wash your hands thoroughly with soap and water before handling supplies
2.Clean the injection site with an alcohol swab and let it air dry completely
3.Pinch a fold of skin at the chosen injection site
4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
5.Inject the medication slowly and steadily over 5-10 seconds
6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab
7.Rotate injection sites to prevent tissue irritation or lipodystrophy
8.Dispose of the needle safely in a sharps container—never recap or reuse needles

Storage

Before reconstitution

Store Apelin-13 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Apelin-13 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

Solution appears cloudy, discolored, or contains visible particles (should be clear)
Product has been exposed to temperatures outside the recommended storage range
Product has been frozen (unless specifically designed for freeze-thaw stability)
Expiration date has passed or reconstituted solution has exceeded its use-by date
Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: Intravenous (IV)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Apelin-13. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is it
safe?

Safety Profile

Apelin-13 is a research compound with no human clinical trials or FDA approval. All safety data comes from animal studies and in vitro mechanistic work showing beneficial effects on vascular function and cardiac remodeling. However, animal models do not predict human safety, and the peptide's effects on immune regulation in humans remain untested. No dose-ranging studies, pharmacokinetics, or organ accumulation data exist in humans. The APJ receptor is expressed in multiple tissues including brain, raising concerns about off-target neurological effects at high doses.

Evidence consists entirely of animal studies in mice, rats, and larger mammals, plus in vitro receptor binding and vascular biology research. No human pharmacokinetics, toxicology screening, Phase 1 safety studies, or clinical efficacy trials have been conducted. The literature base is mechanistic rather than empirical safety data.

Common Side Effects

Experienced by some users

Mild changes in blood pressure